Dr Min Yi Tan Consultant obstetrician and subspecialist in maternal and fetal medicine

- Patient age group
- Adults
- Consultant registered on
- 06/08/2008
- Primary medical qualifications
- MB BCh BAO (Hons), MRCOG, MD (res)
- Foreign languages
- Gender
- Female
- Services
- Hospitals
Background
Ms Min Yi Tan is a consultant obstetrician and an accredited sub-specialist in maternal and fetal medicine at St Mary’s Hospital, London. She has vast experience in the care of both low-risk and high-risk pregnancies, with special interests in fetal ultrasound, early diagnosis of pregnancy complications, and prenatal genetic testing.
Ms Tan graduated with honours from Queen’s University of Belfast and completed postgraduate specialist training in obstetrics and gynaecology in London. She received advanced training in fetal medicine at King’s College Hospital under Professor Kypros Nicolaides. She was awarded an MD from King’s College London for her research on first-trimester screening for pre-eclampsia. Her work is widely published in international journals.
Expertise
Antenatal care, Maternal and fetal medicine, Obstetrics, Pregnancy ultrasound, Prenatal diagnosis, Caesarean births, Natural births, Abortion care
Research & publications
Cavoretto PI, Farina A, Salmeri N, Syngelaki A, Tan MY, Nicolaides KH. First trimester risk of
preeclampsia and rate of spontaneous birth in patients without preeclampsia. Am J Obstet Gynecol.
2024 Jan 18:S0002-9378(24)00022-X.
Nicolaides KH, Syngelaki A, Poon LC, Rolnik DL, Tan MY, Wright A, Wright D. First-trimester prediction of preterm pre-eclampsia and prophylaxis by aspirin: Effect on spontaneous and iatrogenic preterm birth. BJOG. 2024 Mar;131(4):483-492.
Wright D, Wright A, Tan MY, Nicolaides KH. When to give aspirin to prevent preeclampsia: application of Bayesian decision theory. Am J Obstet Gynecol. 2022 Feb;226(2S):S1120-S1125.
Wright D, Tan MY, O'Gorman N, Syngelaki A, Nicolaides KH. Serum PlGF compared with PAPP-A in
first trimester screening for preterm pre-eclampsia: Adjusting for the effect of aspirin treatment. BJOG. 2022 Jul;129(8):1308-1317.
Pikovsky M, Tan MY, Ahmed A, Sykes L, Agha-Jaffar R, Yu CKH. Euglycaemic ketoacidosis in pregnant women with COVID-19: two case reports. BMC Pregnancy Childbirth. 2021 Jun 16;21(1):427.
Kanzara T, Rotman A, Kinshuck A, Al Yaghchi C, Tan MY, Yu C, Sandu G. Endoscopic management of
idiopathic subglottic stenosis in pregnancy. Obstet Med. 2021 Dec;14(4):225-229.
Wright D, Tan MY, O'Gorman N, Poon LC, Syngelaki A, Wright A, Nicolaides KH. Predictive
performance of the competing risk model in screening for preeclampsia. Am J Obstet Gynecol. 2019
Feb;220(2):199.e1-199.e13.
Tan MY, Syngelaki A, Poon LC, Rolnik DL, O'Gorman N, Delgado JL, Akolekar R, Konstantinidou L,
Tsavdaridou M, Galeva S, Ajdacka U, Molina FS, Persico N, Jani JC, Plasencia W, Greco E, Papaioannou G, Wright A, Wright D, Nicolaides KH. Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. Ultrasound Obstet Gynecol. 2018 Aug;52(2):186-195.
Tan MY, Poon LC, Rolnik DL, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh
M, Molina FS, Persico N, Jani JC, Plasencia W, Greco E, Papaioannou G, Wright D, Nicolaides KH.
Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE.
Ultrasound Obstet Gynecol. 2018 Jul;52(1):52-59.
Tan MY, Wright D, Syngelaki A, Akolekar R, Cicero S, Janga D, Singh M, Greco E, Wright A, Maclagan
K, Poon LC, Nicolaides KH. Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE.
Ultrasound Obstet Gynecol. 2018 Jun;51(6):743-750.
Wright D, Rolnik DL, Syngelaki A, de Paco Matallana C, Machuca M, de Alvarado M, Mastrodima S, Yi
Tan M, Shearing S, Persico N, Jani JC, Plasencia W, Papaioannou G, Molina FS, Poon LC, Nicolaides
KH. Aspirin for evidence-based preeclampsia prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit. Am J Obstet Gynecol 2018; pii : S0002-9378(18)30173-X.
Poon LC, Rolnik DL, Tan MY, Delgado JL, Tsokaki T, Akolekar R, Singh M, Andrade W, Efeturk T, Jani
JC, Plasencia W, Papaioannou G, Blazquez AR, Carbone IF, Wright D, Nicolaides KH. ASPRE trial: incidence of preterm preeclampsia in patients fulfilling ACOG and NICE criteria
according to risk by the FMF algorithm. Ultrasound Obstet Gynecol. 2018; 51(6):738-742.
Tan MY, Koutoulas L, Wright D, Nicolaides KH, Poon LCY. Protocol for the prospective validation
study: 'Screening programme for pre-eclampsia' SPREE. Ultrasound Obstet Gynecol 2017; 502:175-
179.
Tan MY, Wright D, Koutoulas L, Akolekar R, Nicolaides KH. Comparison of screening for pre-eclampsia at 31–34 weeks' gestation by sFlt-1/PlGF ratio and a method combining maternal factors with sFlt-1 and PlGF. Ultrasound Obstet Gynecol. 2017; 49: 201–208.
Poon LCY, Tan MY, Yerlikaya G, Syngelaki A, Nicolaides KH. Birth weight in live births and stillbirths.
Ultrasound Obstet Gynecol. 2016; 48: 602–606.
Tan MY, To M. Recent advances in the prevention and management of preterm birth. F1000Prime Reps.2015;7:40